Achyut Healthcare Limited

543499

INE0K1401012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:55 26/06/2024 BST			5-day change	1st Jan Change
50.13 ^INR	+7.78%		-7.17%	-13.57%

05-28	Achyut Healthcare Turns to Profit in Fiscal Q4	MT
01-16	Achyut Healthcare Limited announced that it has received INR 157.248 million in funding	CI

Achyut Healthcare Limited announced that it has received INR 52.08 million in funding from Ray Remedies Private Limited, Sera Investments & Finance India Limited, Everon Advisors Private Limited

January 04, 2023

On January 5, 2023, Achyut Healthcare Limited closed the transaction. The company issued 2,604,000 shares at issue price of INR 20 per share, including the premium of INR 10 per share for total gross proceeds of INR 52,080,000. The paid up share capital of the company increased from INR 67,410,000 to INR 93,450,000.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	ACHYUT HEALTHCARE LIMITED	50.13 INR	+7.78%	-7.17%	9.38M
	SERA INVESTMENTS & FINANCE INDIA LIMITED	17.52 INR	+1.98%	+12.45%	13.38M

Latest news about Achyut Healthcare Limited

Achyut Healthcare Turns to Profit in Fiscal Q4	05-28	MT
Achyut Healthcare Limited announced that it has received INR 157.248 million in funding	01-15	CI
Achyut Healthcare Limited announced that it expects to receive INR 205.758 million in funding	11-14	CI
Achyut Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-04	CI
Achyut Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	27/05/23	CI
Achyut Healthcare Limited Announces Appointment of Company Secretary and Compliance Officer	14/04/23	CI
3,592,800 Equity Shares of Achyut Healthcare Limited are subject to a Lock-Up Agreement Ending on 25-MAR-2023.	24/03/23	CI
Achyut Healthcare Board to Consider Issuance of Bonus Shares	15/03/23	MT
Achyut Healthcare to Allot Nearly 3 Million Shares to Promoters, Non-Promoters	05/01/23	MT
Achyut Healthcare Limited announced that it has received INR 52.08 million in funding from Ray Remedies Private Limited, Sera Investments & Finance India Limited, Everon Advisors Private Limited	04/01/23	CI
Achyut Healthcare Limited announced that it expects to receive funding	16/11/22	CI
Parag Sandip Kumar Dave Resigns as Company Secretary Cum Compliance Officers of Achyut Healthcare	12/11/22	CI
Achyut Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022	12/11/22	CI
Achyut Healthcare Limited has completed an IPO in the amount of INR 36 million.	25/03/22	CI
Achyut Healthcare Limited has filed an IPO.	22/12/21	CI

Chart Achyut Healthcare Limited

Duration

Period

More charts

Company Profile

Achyut Healthcare Limited is an India-based pharmaceutical trading company. The Company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The Company is engaged in the business of pharmaceutical formulations in the forms of tablets, capsules, oral liquid and injectable. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

Sector

Pharmaceuticals

Calendar

10/11/2024 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ACHYUT HEALTHCARE LIMITED	-13.57%	9.38M
ELI LILLY AND COMPANY	+54.61%	815B
NOVO NORDISK A/S	+44.25%	654B
JOHNSON & JOHNSON	-6.33%	354B
MERCK & CO., INC.	+20.62%	337B
ABBVIE INC.	+10.44%	302B
ASTRAZENECA PLC	+18.45%	247B
ROCHE HOLDING AG	+2.09%	229B
NOVARTIS AG	+13.03%	219B
AMGEN INC.	+8.61%	171B

Other Pharmaceuticals